|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
GB9621367D0
(en)
*
|
1996-10-14 |
1996-12-04 |
Isis Innovation |
Chiral peptide nucleic acids
|
|
US6326479B1
(en)
*
|
1998-01-27 |
2001-12-04 |
Boston Probes, Inc. |
Synthetic polymers and methods, kits or compositions for modulating the solubility of same
|
|
WO2000050006A2
(en)
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Microemulsions with adsorbed macromoelecules and microparticles
|
|
WO2002042316A2
(en)
*
|
2000-11-24 |
2002-05-30 |
Pantheco A/S |
Pna analogues
|
|
AU2002216946A1
(en)
*
|
2001-01-05 |
2002-07-16 |
Pantheco A/S |
Modified pna molecules
|
|
US6716961B2
(en)
*
|
2001-10-30 |
2004-04-06 |
Isis Innovation Limited |
Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone
|
|
AU2003244401A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Isis Innovation Limited |
Pyrrolidinyl peptide nucleic acids
|
|
EP2957568B1
(en)
*
|
2002-11-05 |
2016-12-21 |
Ionis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
|
BRPI0410780A
(pt)
*
|
2003-05-20 |
2006-06-27 |
Investigen Inc |
sistema para detectar polinucleotìdeos
|
|
EP1644475A4
(en)
|
2003-06-20 |
2009-06-03 |
Isis Pharmaceuticals Inc |
DOUBLE-STRAND COMPOSITIONS WITH A 3'-ENDO-MODIFIED STRING FOR USE IN GENE MODULATION
|
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
|
WO2007100711A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
EP2099816A1
(en)
|
2006-12-04 |
2009-09-16 |
Luminex Corporation |
Oxocarbonamide peptide nucleic acids and methods of using same
|
|
WO2008103702A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
US7964355B2
(en)
*
|
2009-02-17 |
2011-06-21 |
Investigen, Inc. |
Assays based on detection of photobleaching reaction products from dye catalytic complex
|
|
US8785121B2
(en)
|
2010-07-08 |
2014-07-22 |
Bonac Corporation |
Single-stranded nucleic acid molecule for controlling gene expression
|
|
US8691782B2
(en)
|
2010-08-03 |
2014-04-08 |
Bonac Corporation |
Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
|
|
KR101894702B1
(ko)
*
|
2010-08-03 |
2018-09-04 |
가부시키가이샤 보낙 |
함질소 지환식 골격을 갖는 일본쇄 핵산 분자
|
|
EP2857513A4
(en)
|
2012-05-26 |
2016-05-25 |
Bonac Corp |
Single-stranded nucleic acid molecule controlling the expression of a gene transporter
|
|
US10612020B2
(en)
|
2013-12-26 |
2020-04-07 |
Tokyo Medical University |
Artificial mimic miRNA for controlling gene expression, and use of same
|
|
BR112016014986A2
(pt)
|
2013-12-27 |
2018-01-23 |
Bonac Corporation |
mirna tipo correspondência artificial, composição e método para suprimir expressão de um gene alvo, composição farmacêutica, método para tratar uma doença, e, ácido nucleico de fita única
|
|
RU2740032C2
(ru)
|
2014-12-27 |
2020-12-30 |
Бонак Корпорейшн |
ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ
|
|
HK1244031A1
(en)
|
2015-03-27 |
2018-07-27 |
Bonac Corporation |
Single-chain nucleic acid molecule having delivery function and gene expression control ability
|